January 19, 2018 9:23 AM ET

Biotechnology

Company Overview of Takeda Vaccines (Montana), Inc.

Key Executives for Takeda Vaccines (Montana), Inc.

NameBoard RelationshipsTitleAge
Larry W. Mikkola MBA, CPANo RelationshipsDirector of Finance and Controller--
Robert R. Goodwin Ph.D.No RelationshipsVice President--
Paul M. Mendelman M.D.26 RelationshipsVice President of Medicine69
Charles E. Richardson Ph.D.No RelationshipsExecutive Vice President of Research & Development65

Takeda Vaccines (Montana), Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
J. Donald deBethizy Ph.D. 79 RelationshipsNOXXON Pharma N.V.66
Russell C. Middaugh Ph.D., A. & T. 6 RelationshipsTakeda Vaccines (Montana), Inc.--
Jerry McGhee Ph.D. 6 RelationshipsTakeda Vaccines (Montana), Inc.--
Marian Neutra Ph.D., E. & M. 6 RelationshipsTakeda Vaccines (Montana), Inc.--
Bryan Finkle Ph.D. 6 RelationshipsTakeda Vaccines (Montana), Inc.--
View All Board Members

Takeda Vaccines (Montana), Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
407.6K
Bonus
223.9K
Total Short Term Compensation
474.9K
Total Value of Options
18.2M
Compensation as of Fiscal Year
Takeda Vaccines (Montana), Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Zealand Pharma A/S Appoints Ivan Møller as Senior Vice President, Technical Development & Operations, Effective March 1, 2018
January 19, 2018 8:09 AM ET
Medibio Limited Announces Resignation of Adam Darkins from the Board of Directors
January 18, 2018 11:01 PM ET
DanDrit Biotech USA, Inc. Announces Executive Appointments
January 18, 2018 9:22 PM ET
Charles A. Baker Announces Intention Not to Stand for Re-Election as Member of Board of Directors of Regeneron Pharmaceuticals, Inc
January 18, 2018 9:01 PM ET
Immunovaccine Inc. Appoints Joseph Sullivan as Senior Vice President, Business Development, Effective January 22, 2018
January 18, 2018 2:58 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Takeda Vaccines (Montana), Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.